PolyU collaborates with Axis Therapeutics to establish joint laboratory for immunotherapy (IMAGE)

The Hong Kong Polytechnic University

PolyU collaborates with Axis Therapeutics to establish joint laboratory for immunotherapy

Caption

Witnessed by Prof. Wing-tak Wong, PolyU’s Deputy President and Provost (back row, 2nd from right); Mr Yonghui Wang, Chairman/President of Xiangxue Pharmaceutical Co Ltd and President of Axis (back row, 2nd from left) ; Mr Kejian Zhang, Chairman of the Strategic Development Committee of XLifeSc (back row, 1st from left) ; and Dr Johnson Yiu Nam Lau, co-founder of Axis and Adjunct Professor of the Department of Applied Biology and Chemical Technology of PolyU (back row, 1st from right), the agreement for the establishment of the PolyU-Axis Therapeutics Joint Laboratory for Immunotherapy was signed by Prof. Larry Ming Cheung Chow, Head of the Department of Applied Biology and Chemical Technology of PolyU (front row, right); and Dr Lun Zeng, CEO of Axis and CEO of XLifeSc (front row, left).

Credit

© 2024 Research and Innovation Office, The Hong Kong Polytechnic University. All Rights Reserved.

Usage Restrictions

Nil

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.